Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3740525017 | Grepafloxacin only product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3740526016 | Product containing only grepafloxacin in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Grepafloxacin only product in oral dose form | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Grepafloxacin only product in oral dose form | Has active ingredient | Grepafloxacin (substance) | true | Inferred relationship | Some | 1 | |
| Grepafloxacin only product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
| Grepafloxacin only product in oral dose form | Is a | Product containing only grepafloxacin (medicinal product) | true | Inferred relationship | Some | ||
| Grepafloxacin only product in oral dose form | Is a | Grepafloxacin-containing product in oral dose form | true | Inferred relationship | Some | ||
| Grepafloxacin only product in oral dose form | Plays role | Antibacterial therapeutic role (role) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Grepafloxacin 400 mg oral tablet | Is a | True | Grepafloxacin only product in oral dose form | Inferred relationship | Some | |
| Product containing precisely grepafloxacin 200 milligram/1 each conventional release oral tablet (clinical drug) | Is a | True | Grepafloxacin only product in oral dose form | Inferred relationship | Some | |
| Product containing precisely grepafloxacin 600 milligram/1 each conventional release oral tablet (clinical drug) | Is a | True | Grepafloxacin only product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR